Opus Genetics (IRD) Treasury Shares (2010 - 2026)
Opus Genetics (IRD) reported Treasury Shares of $128410.0 for Q3 2015, little changed year-over-year from $128410.0 in Q3 2014, and little changed on a QoQ basis from $128410.0 in Q2 2015.
Opus Genetics (IRD) has 6 years of Treasury Shares data on file, last reported at $128410.0 in Q3 2015.
- Quarterly Treasury Shares changed 0.0% year-over-year to $128410.0 in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $128410.0 (changed 0.0% YoY) and the FY2014 annual result came in at $128410.0, up 351.99% from the prior year.
- Treasury Shares was little changed at $128410.0 in Q3 2015 per IRD's latest filing, from $128410.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $29.4 million in Q1 2025 and bottomed at $801700.0 in Q1 2023.
- The 4-year median for Treasury Shares is $22.9 million (2025), against an average of $16.0 million.
- The widest annual swing landed in 2011, when Treasury Shares changed 0.0%; it then surged 351.99% in 2014.
- Tracing IRD's Treasury Shares over 5 years: stood at $28410.0 in 2011, then changed by 0.0% to $28410.0 in 2012, then changed by 0.0% to $28410.0 in 2013, then jumped by 351.99% to $128410.0 in 2014, then changed by 0.0% to $128410.0 in 2015.
- Per Business Quant, the three latest IRD Treasury Shares figures stand at $128410.0 (Q3 2015), $128410.0 (Q2 2015), and $128410.0 (Q1 2015).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | 22.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.90 Mn |
| Mar 31, 2026 | 22.90 Mn |
| Dec 31, 2025 | 22.90 Mn |
| Dec 31, 2025 | 22.90 Mn |
| Sep 30, 2025 | 29.43 Mn |
| Sep 30, 2025 | 29.43 Mn |
| Jun 30, 2025 | 29.43 Mn |
| Jun 30, 2025 | 29.43 Mn |
| Mar 31, 2025 | 29.43 Mn |
| Mar 31, 2025 | 29.43 Mn |
| Dec 31, 2024 | 7.20 Mn |
| Dec 31, 2024 | 7.20 Mn |
| Mar 31, 2024 | 1.39 Mn |
| Mar 31, 2024 | 1.39 Mn |
| Dec 31, 2023 | 801,700.00 |
| Dec 31, 2023 | 801,700.00 |
| Mar 31, 2023 | 801,700.00 |
| Mar 31, 2023 | 801,700.00 |
| Dec 31, 2020 | 40,000.00 |
| Dec 31, 2020 | 40,000.00 |
| Jun 30, 2019 | 271.00 |
| Jun 30, 2019 | 271.00 |
| Mar 31, 2019 | 271.00 |
| Mar 31, 2019 | 271.00 |
| Dec 31, 2018 | 64,552.00 |
| Dec 31, 2018 | 64,552.00 |
| Sep 30, 2018 | 35,475.00 |
| Sep 30, 2018 | 35,475.00 |
| Jun 30, 2018 | 35,475.00 |
| Jun 30, 2018 | 35,475.00 |
| Mar 31, 2018 | 35,475.00 |
| Mar 31, 2018 | 35,475.00 |
| Dec 31, 2017 | 47,300.00 |
| Dec 31, 2017 | 47,300.00 |
| Sep 30, 2017 | 47,300.00 |
| Sep 30, 2017 | 47,300.00 |
| Jun 30, 2017 | 54,300.00 |
| Jun 30, 2017 | 54,300.00 |
| Mar 31, 2017 | 543,000.00 |
| Mar 31, 2017 | 543,000.00 |
| Sep 30, 2015 | 113,215.00 |
| Sep 30, 2015 | 128,410.00 |
| Sep 30, 2015 | 128,410.00 |
| Sep 30, 2015 | 113,215.00 |
| Jun 30, 2015 | 128,410.00 |
| Jun 30, 2015 | 113,215.00 |
| Jun 30, 2015 | 113,215.00 |
| Jun 30, 2015 | 128,410.00 |
| Mar 31, 2015 | 113,215.00 |
| Mar 31, 2015 | 128,410.00 |
| Mar 31, 2015 | 128,410.00 |
| Mar 31, 2015 | 113,215.00 |
| Dec 31, 2014 | 128,410.00 |
| Dec 31, 2014 | 128,410.00 |
| Dec 31, 2014 | 113,215.00 |
| Dec 31, 2014 | 113,215.00 |
| Sep 30, 2014 | 113,215.00 |
| Sep 30, 2014 | 113,215.00 |
| Sep 30, 2014 | 128,410.00 |
| Sep 30, 2014 | 128,410.00 |
| Jun 30, 2014 | 113,215.00 |
| Jun 30, 2014 | 113,215.00 |
| Jun 30, 2014 | 128,410.00 |
| Jun 30, 2014 | 128,410.00 |
| Mar 31, 2014 | 28,410.00 |
| Mar 31, 2014 | 14,205.00 |
| Mar 31, 2014 | 14,205.00 |
| Mar 31, 2014 | 28,410.00 |
| Dec 31, 2013 | 28,410.00 |
| Dec 31, 2013 | 14,205.00 |
| Dec 31, 2013 | 14,205.00 |
| Dec 31, 2013 | 28,410.00 |
| Sep 30, 2013 | 28,410.00 |
| Sep 30, 2013 | 28,410.00 |
| Sep 30, 2013 | 14,205.00 |
| Sep 30, 2013 | 14,205.00 |
| Jun 30, 2013 | 800,000.00 |
| Jun 30, 2013 | 800,000.00 |
| Jun 30, 2013 | 28,410.00 |
| Jun 30, 2013 | 28,410.00 |
| Mar 31, 2013 | 28,410.00 |
| Mar 31, 2013 | 800,000.00 |
| Mar 31, 2013 | 28,410.00 |
| Mar 31, 2013 | 800,000.00 |
| Dec 31, 2012 | 28,410.00 |
| Dec 31, 2012 | 14,205.00 |
| Dec 31, 2012 | 14,205.00 |
| Dec 31, 2012 | 28,410.00 |
| Sep 30, 2012 | 14,205.00 |
| Sep 30, 2012 | 14,205.00 |
| Sep 30, 2012 | 28,410.00 |
| Sep 30, 2012 | 28,410.00 |
| Jun 30, 2012 | 28,410.00 |
| Jun 30, 2012 | 14,205.00 |
| Jun 30, 2012 | 14,205.00 |
| Jun 30, 2012 | 28,410.00 |
| Mar 31, 2012 | 28,410.00 |
| Mar 31, 2012 | 14,205.00 |
| Mar 31, 2012 | 14,205.00 |
| Mar 31, 2012 | 28,410.00 |
| Dec 31, 2011 | 14,205.00 |
| Dec 31, 2011 | 28,410.00 |
| Dec 31, 2011 | 14,205.00 |
| Dec 31, 2011 | 28,410.00 |
| Sep 30, 2011 | 28,410.00 |
| Sep 30, 2011 | 14,205.00 |
| Sep 30, 2011 | 14,205.00 |
| Sep 30, 2011 | 28,410.00 |
| Jun 30, 2011 | 14,205.00 |
| Jun 30, 2011 | 28,410.00 |
| Jun 30, 2011 | 28,410.00 |
| Jun 30, 2011 | 14,205.00 |
| Dec 31, 2010 | 14,205.00 |
| Dec 31, 2010 | 14,205.00 |
| Dec 31, 2010 | 28,410.00 |
| Dec 31, 2010 | 28,410.00 |